文献速递细菌感染、耐药与抗菌药物

药师参与的干预措施对全科医生抗生素处方有效性的系统评价与荟萃分析

Effectiveness of interventions involving pharmacists on antibiotic prescribing by general practitioners: a systematic review and meta-analysis.
PubMed 文献 · J Antimicrob Chemother · 2019-01-01

结果显示,药师参与的ASP可降低APR(OR 0.86,95%CI 0.78-0.95)并提高APAR(OR 1.96,95%CI 1.56-2.45),但存在显著异质性。

要点

  • 药师参与的ASP可降低全科医生抗生素处方率并提高指南依从率。
  • 高质量随机试验中效应更显著:APR降低(OR 0.92),APAR提高(OR 2.55)。
  • 药师-全科医生团队及药师-感染病专业团队干预均有效,但研究间异质性较大。

核心结论

  • 药师参与的ASP能有效减少全科医生的抗生素处方并增加指南依从性处方。

主要发现

  • 中位随访6个月时,APR降低(OR 0.86,95%CI 0.78-0.95,中等质量证据),APAR提高(OR 1.96,95%CI 1.56-2.45,高质量证据)。
  • 高质量随机试验中APR降低(OR 0.92,95%CI 0.90-0.94),APAR提高(OR 2.55,95%CI 2.16-3.01)。
  • 药师-全科医生团队干预降低APR(OR 0.93,95%CI 0.90-0.95)并提高APAR(OR 1.72,95%CI 1.04-2.84)。
  • 药师-感染病专业团队干预降低APR(OR 0.81,95%CI 0.66-1.0)并提高APAR(OR 2.36,95%CI 1.87-2.96)。
  • 全科医生教育加处方反馈及小组会议对两项结局均有效,而全科医生教育、学术 detailing 和 workshop 培训仅对APAR有效。

关键数值与推荐

  • APR降低的合并OR为0.86(95%CI 0.78-0.95),APAR提高的合并OR为1.96(95%CI 1.56-2.45)。
  • 高质量随机试验中APR降低OR 0.92(95%CI 0.90-0.94),APAR提高OR 2.55(95%CI 2.16-3.01)。

临床怎么用

  • 在社区抗生素管理项目中纳入药师可改善全科医生处方行为,尤其应优先采用药师-全科医生团队及药师-感染病专业团队模式。

局限性

  • 研究间存在显著异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of community antibiotic stewardship programmes (ASPs) is rising; however, their effectiveness when pharmacists are involved is uncertain. OBJECTIVES: To assess the effectiveness of ASPs involving pharmacists at improving antibiotic prescribing by general practitioners (GPs). METHODS: Medline, Embase, Emcare, PubMed, PsycINFO, Cochrane CENTRAL, CINAHL Plus and Web of Science databases were searched to February 2018. Randomized and non-randomized studies of ASPs involving pharmacists as interventionists to GPs were included. Primary outcomes were absolute changes in GPs' antibiotic prescribing rate (APR) and antibiotic prescribing adherence rate (APAR) according to recommendations/guidelines. Meta-analysis used random effects models. RESULTS: Fifteen studies reporting 18 trials were included in the meta-analysis: 8 assessed the APR and 10 the APAR. APR reductions (OR 0.86, 95% CI 0.78-0.95, moderate-certainty evidence) and APAR improvements (OR 1.96, 95% CI 1.56-2.45, high-certainty evidence) were observed at 6 months median intervention follow-up. High-quality randomized trials reduced the APR (OR 0.92, 95% CI 0.90-0.94) and increased the APAR (OR 2.55, 95% CI 2.16-3.01). Interventions were successful in decreasing the APR (OR 0.93, 95% CI 0.90-0.95) and increasing the APAR (OR 1.72, 95% CI 1.04-2.84) when implemented by a pharmacist-GP team. Interventions involving pharmacist-infectious disease professional teams also decreased the APR (OR 0.81, 95% CI 0.66-1.0) and increased the APAR (OR 2.36, 95% CI 1.87-2.96). GP education plus prescribing feedback, and group meetings were effective in both outcomes, whereas GP education, academic detailing and workshop training were effective in APAR outcome. However, substantial heterogeneity was demonstrated. CONCLUSIONS: ASPs involving pharmacists are effective in decreasing antibiotic prescribing and increasing guideline-adherent antibiotic prescribing by GPs.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Saha SK, Hawes L, Mazza D, et al. Effectiveness of interventions involving pharmacists on antibiotic prescribing by general practitioners: a systematic review and meta-analysis. J Antimicrob Chemother. 2019. PMID: 30698721. doi:10.1093/jac/dky572

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。